In the first three patients treated, two showed complete responses, with full disappearance of enhancing tumor lesions, while the third showed stable disease with a 30% reduction in tumor size.
No unanticipated serious adverse events were observed as… [1464 chars]
Alpha Tau Medical Stock Surges As Interim Brain Tumor Trial Data Sparks Rally
